Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shannon Meeks

13PUBLICATIONS
41CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHealth equityMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Dec 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Amy Dunn, Yesim Dargaud, Yasmina Abajas

|Nov 25, 2024
Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical, humoral and cellular immune responses.

Christoph Königs, Shannon L Meeks, Beatrice Nolan

|Mar 28, 2024
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?

Shannon L Meeks, Karen L Zimowski

|Mar 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.

Duc Q Tran, Craig C Benson, Judith A Boice

|Mar 11, 2023
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.

Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan

|Apr 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.

Steven W Pipe, Cédric Hermans, Meera Chitlur

Pageof 3

Frequent Collaborators

3 joint publications

Pete Lollar

2 joint publications

Glaivy Batsuli

2 joint publications

Guy Young

2 joint publications

Johnny Mahlangu

2 joint publications

Miguel Escobar

2 joint publications

Amy L Dunn

2 joint publications

Manuel Carcao

2 joint publications

Giancarlo Castaman

1 joint publications

Thomas A Wilkinson

1 joint publications

Philip M Zakas

Frequent Collaborators

3 joint publications

Pete Lollar

2 joint publications

Glaivy Batsuli

2 joint publications

Guy Young

2 joint publications

Johnny Mahlangu

Top Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on : Sep 30, 2021

6.0K
<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on : Aug 12, 2017

14.3K
See more related videos

Top Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on : Sep 30, 2021

6.0K
<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on : Aug 12, 2017

14.3K
See more related videos